Nifty
Sensex
:
:
11050.25
37388.66
244.70 (2.26%)
835.06 (2.28%)

Pharmaceuticals & Drugs - Global

Rating :
68/99

BSE: 530549 | NSE: SHILPAMED

565.00
25-Sep-2020
  • Open
  • High
  • Low
  • Previous Close
  •  559.70
  •  573.70
  •  553.65
  •  551.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  670049
  •  3778.26
  •  695.00
  •  233.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,607.90
  • 20.32
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,953.22
  • 0.19%
  • 3.25

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.80%
  • 5.04%
  • 11.09%
  • FII
  • DII
  • Others
  • 19.03%
  • 7.36%
  • 3.68%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.08
  • 4.85
  • 4.80

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.76
  • 6.04
  • 7.24

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.23
  • 7.34
  • 11.65

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.92
  • 32.96
  • 25.65

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.05
  • 4.22
  • 3.00

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.85
  • 22.20
  • 17.96

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
222.87
160.99
38.44%
219.99
199.52
10.26%
236.85
173.43
36.57%
289.92
162.28
78.65%
Expenses
157.11
132.19
18.85%
174.40
162.11
7.58%
163.11
147.25
10.77%
221.91
124.75
77.88%
EBITDA
65.75
28.80
128.30%
45.60
37.40
21.93%
73.74
26.18
181.67%
68.00
37.53
81.19%
EBIDTM
29.50%
17.89%
14.01%
18.75%
31.13%
15.09%
23.46%
23.13%
Other Income
5.48
1.98
176.77%
8.91
3.09
188.35%
3.25
3.13
3.83%
5.82
3.15
84.76%
Interest
4.00
1.46
173.97%
1.01
1.41
-28.37%
1.27
1.07
18.69%
0.82
0.63
30.16%
Depreciation
12.33
10.66
15.67%
11.55
10.54
9.58%
10.97
11.25
-2.49%
10.66
10.00
6.60%
PBT
115.74
18.66
520.26%
41.57
28.09
47.99%
64.76
11.24
476.16%
62.34
56.12
11.08%
Tax
29.14
4.05
619.51%
7.55
5.61
34.58%
10.53
-0.46
-
11.18
11.39
-1.84%
PAT
86.60
14.61
492.74%
34.02
22.49
51.27%
54.24
11.70
363.59%
51.16
44.73
14.38%
PATM
38.86%
9.07%
7.11%
11.27%
22.90%
6.75%
17.65%
27.56%
EPS
10.63
1.79
493.85%
4.17
2.76
51.09%
6.65
1.44
361.81%
6.28
5.49
14.39%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
969.63
907.91
733.39
788.83
779.16
716.43
613.80
571.38
371.32
318.18
290.29
Net Sales Growth
39.27%
23.80%
-7.03%
1.24%
8.76%
16.72%
7.42%
53.88%
16.70%
9.61%
 
Cost Of Goods Sold
4,864.24
277.73
256.57
355.87
371.81
366.19
323.16
313.26
213.95
183.22
162.98
Gross Profit
-3,894.61
630.18
476.81
432.95
407.36
350.25
290.63
258.12
157.38
134.96
127.31
GP Margin
-401.66%
69.41%
65.01%
54.89%
52.28%
48.89%
47.35%
45.17%
42.38%
42.42%
43.86%
Total Expenditure
716.53
693.39
579.40
637.60
617.55
556.44
487.38
455.40
301.63
257.08
219.70
Power & Fuel Cost
-
38.76
33.55
28.86
26.30
21.90
19.29
17.37
10.67
9.38
7.03
% Of Sales
-
4.27%
4.57%
3.66%
3.38%
3.06%
3.14%
3.04%
2.87%
2.95%
2.42%
Employee Cost
-
196.59
176.40
149.35
127.87
90.09
82.30
67.83
42.56
33.68
28.37
% Of Sales
-
21.65%
24.05%
18.93%
16.41%
12.57%
13.41%
11.87%
11.46%
10.59%
9.77%
Manufacturing Exp.
-
79.19
60.96
59.96
52.55
45.35
36.55
27.44
16.92
12.89
8.35
% Of Sales
-
8.72%
8.31%
7.60%
6.74%
6.33%
5.95%
4.80%
4.56%
4.05%
2.88%
General & Admin Exp.
-
70.26
27.05
22.50
16.95
14.11
10.64
9.53
9.51
7.87
5.64
% Of Sales
-
7.74%
3.69%
2.85%
2.18%
1.97%
1.73%
1.67%
2.56%
2.47%
1.94%
Selling & Distn. Exp.
-
10.40
6.66
6.37
4.75
7.27
5.99
7.29
4.43
3.19
4.63
% Of Sales
-
1.15%
0.91%
0.81%
0.61%
1.01%
0.98%
1.28%
1.19%
1.00%
1.59%
Miscellaneous Exp.
-
20.47
18.20
14.68
17.32
11.54
9.45
12.68
3.59
6.86
4.63
% Of Sales
-
2.25%
2.48%
1.86%
2.22%
1.61%
1.54%
2.22%
0.97%
2.16%
0.93%
EBITDA
253.09
214.52
153.99
151.23
161.61
159.99
126.42
115.98
69.69
61.10
70.59
EBITDA Margin
26.10%
23.63%
21.00%
19.17%
20.74%
22.33%
20.60%
20.30%
18.77%
19.20%
24.32%
Other Income
23.46
22.22
15.57
32.62
29.34
11.36
6.93
9.12
5.01
8.28
8.95
Interest
7.10
4.56
3.68
2.66
3.13
3.93
4.05
3.52
2.27
2.31
2.63
Depreciation
45.51
43.78
42.06
37.22
30.64
23.14
21.41
23.22
15.34
14.36
12.96
PBT
284.41
188.40
123.82
143.96
157.17
144.28
107.89
98.35
57.10
52.71
63.95
Tax
58.40
33.49
26.18
33.91
42.04
35.62
35.22
20.30
9.53
12.22
14.60
Tax Rate
20.53%
17.78%
18.22%
23.56%
27.54%
25.11%
32.66%
21.27%
16.72%
22.91%
22.83%
PAT
226.02
156.50
120.28
112.43
113.71
109.84
73.69
75.67
47.35
41.23
49.35
PAT before Minority Interest
226.79
154.91
117.52
110.05
110.59
106.24
72.62
75.15
47.47
41.11
49.35
Minority Interest
0.77
1.59
2.76
2.38
3.12
3.60
1.07
0.52
-0.12
0.12
0.00
PAT Margin
23.31%
17.24%
16.40%
14.25%
14.59%
15.33%
12.01%
13.24%
12.75%
12.96%
17.00%
PAT Growth
141.66%
30.11%
6.98%
-1.13%
3.52%
49.06%
-2.62%
59.81%
14.84%
-16.45%
 
EPS
27.73
19.20
14.76
13.80
13.95
13.48
9.04
9.28
5.81
5.06
6.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,329.36
1,197.58
1,085.03
986.90
639.26
546.94
396.45
320.42
275.98
224.68
Share Capital
8.15
8.15
8.15
8.01
7.71
7.71
7.36
4.90
4.90
4.80
Total Reserves
1,321.21
1,189.43
1,076.88
978.88
631.55
539.23
389.09
315.52
271.07
213.85
Non-Current Liabilities
256.94
166.62
153.48
251.26
67.23
154.15
104.53
98.51
31.13
31.85
Secured Loans
164.48
80.39
67.09
141.20
0.03
71.03
37.43
70.47
5.07
11.42
Unsecured Loans
0.53
0.70
1.03
1.30
0.00
31.30
30.05
0.00
0.00
0.00
Long Term Provisions
26.17
21.77
20.32
16.89
13.96
11.75
9.93
6.92
6.34
5.71
Current Liabilities
407.74
253.54
265.84
236.90
222.07
189.06
166.84
123.77
121.14
80.21
Trade Payables
89.46
82.58
103.74
111.86
106.48
75.50
92.98
51.26
56.72
27.90
Other Current Liabilities
142.11
79.86
59.59
28.03
36.49
49.32
38.23
23.38
20.34
16.65
Short Term Borrowings
165.27
86.58
98.12
92.41
74.10
58.47
30.27
45.07
41.24
33.15
Short Term Provisions
10.90
4.52
4.39
4.60
5.00
5.77
5.37
4.06
2.83
2.51
Total Liabilities
1,986.13
1,610.12
1,499.13
1,472.22
930.89
904.54
677.83
551.42
433.11
338.21
Net Block
650.44
558.01
534.20
491.93
393.41
316.06
294.42
180.67
166.61
146.25
Gross Block
986.42
853.16
793.24
704.89
582.20
476.34
448.38
300.89
271.30
232.84
Accumulated Depreciation
335.98
295.15
259.04
212.96
188.79
160.28
153.96
120.22
104.70
86.59
Non Current Assets
1,365.35
1,064.96
827.16
742.33
576.68
576.77
443.89
339.18
244.95
159.79
Capital Work in Progress
666.25
429.12
209.85
140.51
91.90
221.62
111.03
129.15
57.71
2.72
Non Current Investment
10.45
2.25
20.79
27.99
34.15
0.19
0.21
0.14
0.11
3.65
Long Term Loans & Adv.
32.42
48.75
37.47
77.09
51.86
38.74
38.18
28.82
20.17
6.62
Other Non Current Assets
5.78
26.84
24.86
4.80
5.36
0.16
0.06
0.40
0.34
0.00
Current Assets
620.78
545.16
671.97
729.88
354.21
327.61
233.74
211.99
187.87
178.39
Current Investments
0.00
0.00
119.54
224.62
59.63
65.35
10.14
50.28
68.02
0.00
Inventories
226.43
187.67
188.71
190.00
134.23
130.78
123.25
74.33
67.32
43.33
Sundry Debtors
243.72
203.73
220.27
170.93
125.43
81.37
67.96
41.79
40.53
40.13
Cash & Bank
44.56
94.54
73.83
100.39
11.03
18.42
9.19
16.87
2.27
87.20
Other Current Assets
106.06
45.04
26.08
22.00
23.90
31.69
23.20
28.72
9.72
7.72
Short Term Loans & Adv.
29.25
14.18
43.54
21.95
8.90
4.91
3.23
2.86
3.01
1.56
Net Current Assets
213.04
291.62
406.13
492.98
132.14
138.55
66.90
88.22
66.73
98.18
Total Assets
1,986.13
1,610.12
1,499.13
1,472.21
930.89
904.54
677.83
551.42
433.10
338.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
123.72
138.76
44.92
37.48
128.70
68.81
70.04
43.64
56.73
40.86
PBT
188.40
135.68
136.77
146.49
140.36
107.84
95.45
57.00
53.51
64.13
Adjustment
41.32
20.44
18.83
17.19
20.61
26.46
19.62
11.52
10.19
10.42
Changes in Working Capital
-63.80
18.71
-69.66
-92.61
-2.70
-40.11
-23.44
-13.90
0.77
-21.04
Cash after chg. in Working capital
165.92
174.83
85.94
71.08
158.27
94.19
91.62
54.62
64.46
53.51
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-42.20
-36.07
-41.02
-33.60
-29.56
-25.38
-21.58
-10.98
-7.73
-12.61
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-288.85
-188.15
-8.76
-262.23
-109.20
-195.18
-48.93
-95.21
-152.31
7.77
Net Fixed Assets
-4.28
-256.96
-136.75
-172.23
-92.14
-78.46
-61.02
-83.52
-79.20
-5.23
Net Investments
-4.44
141.85
95.51
-172.72
-14.09
-64.38
12.08
13.84
-73.05
-24.39
Others
-280.13
-73.04
32.48
82.72
-2.97
-52.34
0.01
-25.53
-0.06
37.39
Cash from Financing Activity
175.50
10.06
-60.91
312.70
-19.65
135.05
-28.34
66.31
10.02
35.93
Net Cash Inflow / Outflow
10.38
-39.32
-24.75
87.95
-0.15
8.68
-7.23
14.74
-85.56
84.56
Opening Cash & Equivalents
34.36
73.83
99.97
7.05
3.61
9.19
16.87
2.27
87.83
2.65
Closing Cash & Equivalent
44.56
34.36
73.83
99.97
6.43
18.42
9.19
16.87
2.27
87.20

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
163.06
146.89
133.09
123.17
82.91
70.92
107.72
43.52
74.94
60.67
ROA
8.62%
7.56%
7.41%
9.20%
11.58%
9.18%
12.23%
9.64%
10.66%
16.84%
ROE
12.26%
10.30%
10.62%
13.60%
17.92%
15.40%
20.98%
15.93%
16.63%
30.96%
ROCE
12.41%
11.05%
11.71%
15.91%
19.90%
17.90%
20.48%
15.04%
18.02%
28.98%
Fixed Asset Turnover
0.99
0.89
1.06
1.22
1.36
1.34
1.54
1.32
1.28
1.30
Receivable days
89.94
105.51
90.20
69.00
52.26
43.99
34.62
39.70
45.47
46.24
Inventory Days
83.24
93.66
87.32
75.49
66.97
74.84
62.33
68.31
62.38
57.79
Payable days
46.83
58.66
61.51
60.89
60.10
62.86
57.06
63.94
59.10
55.44
Cash Conversion Cycle
126.35
140.51
116.00
83.61
59.13
55.97
39.90
44.07
48.76
48.59
Total Debt/Equity
0.29
0.16
0.18
0.24
0.14
0.34
0.30
0.41
0.22
0.26
Interest Cover
42.34
40.09
55.10
49.69
37.07
27.63
28.09
26.13
24.13
25.28

News Update:


  • Shilpa Medicare gets nod to establish whole owned subsidiary in Malaysia
    18th Sep 2020, 14:40 PM

    The Board of Directors of the company at its meeting held on September 18, 2020 approved the same

    Read More
  • Shilpa Medicare forays into OTC segment
    25th Aug 2020, 09:29 AM

    The company has forayed into OTC segment with the launch of ready-to-drink green tea films

    Read More
  • Shilpa Medicare reports 5-fold jump in Q1 consolidated net profit
    10th Aug 2020, 10:55 AM

    Total consolidated income of the company increased by 40.12% at Rs 228.35 crore for Q1FY21

    Read More
  • Shilpa Medicare - Quarterly Results
    8th Aug 2020, 18:16 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.